Mansfield, TX, United States of America

Kerry L Markwardt

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 138(Granted Patents)


Location History:

  • Mansfield, TX (US) (2001 - 2007)
  • Burleson, TX (US) (2010 - 2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Kerry L Markwardt

Introduction

Kerry L Markwardt is a notable inventor based in Mansfield, TX (US), recognized for his contributions to the field of ophthalmic surgery. With a total of 8 patents to his name, he has made significant advancements in the use of viscoelastic compositions during surgical procedures.

Latest Patents

Among his latest patents is a groundbreaking invention that focuses on combinations of viscoelastics for use during surgery. This improved viscoelastic composition is particularly useful in ophthalmic surgical procedures, especially cataract surgeries. The composition comprises combinations of sodium hyaluronate and chondroitin sulfate, which exhibit an enhanced rheological profile, thereby improving surgical outcomes.

Career Highlights

Kerry has had a distinguished career, working with prominent companies such as Alcon, Inc. and Alcon Manufacturing, Ltd. His work has been pivotal in advancing surgical techniques and improving patient care in ophthalmology.

Collaborations

Throughout his career, Kerry has collaborated with talented professionals, including Uday Doshi and Mandar V Shah. These collaborations have contributed to the innovative solutions he has developed in the field.

Conclusion

Kerry L Markwardt's contributions to ophthalmic surgery through his innovative patents and collaborations highlight his significant impact on the medical field. His work continues to influence surgical practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…